Axon Enterprise Files 8-K: Director Changes & Shareholder Votes
Ticker: AXON · Form: 8-K · Filed: May 13, 2024 · CIK: 1069183
Sentiment: neutral
Topics: corporate-governance, director-changes, shareholder-vote
Related Tickers: AXON
TL;DR
Axon's 8-K drops: Director shuffle, shareholder votes, and financials out May 10th.
AI Summary
Axon Enterprise, Inc. filed an 8-K on May 13, 2024, reporting on the departure of a director, election of new directors, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits. The report date is May 10, 2024.
Why It Matters
This filing provides crucial updates on Axon's corporate governance and potential shareholder decisions, impacting investor confidence and strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate governance and financial information, not indicating any immediate operational or financial distress.
Key Players & Entities
- AXON ENTERPRISE, INC. (company) — Registrant
- TASER INTERNATIONAL INC (company) — Former company name
- May 10, 2024 (date) — Date of earliest event reported
- May 13, 2024 (date) — Date of report
FAQ
Who has departed from Axon Enterprise's board of directors?
The filing indicates the departure of a director, but the specific name is not provided in the excerpt.
Were any new directors elected to the board?
Yes, the filing states the election of directors as part of the reported items.
What other significant items are reported in this 8-K filing?
The filing also covers compensatory arrangements of certain officers and the submission of matters to a vote of security holders.
What is the principal executive office address for Axon Enterprise?
The principal executive offices are located at 17800 N. 85th St., Scottsdale, Arizona 85255.
When was Axon Enterprise previously known as TASER INTERNATIONAL INC?
The company changed its name from TASER INTERNATIONAL INC on February 12, 2001.
Filing Stats: 1,435 words · 6 min read · ~5 pages · Grade level 11.5 · Accepted 2024-05-13 16:54:33
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 Par Value AXON The Nasdaq Global Se
Filing Documents
- axon-20240510x8k.htm (8-K) — 100KB
- 0001069183-24-000037.txt ( ) — 235KB
- axon-20240510.xsd (EX-101.SCH) — 4KB
- axon-20240510_def.xml (EX-101.DEF) — 3KB
- axon-20240510_lab.xml (EX-101.LAB) — 21KB
- axon-20240510_pre.xml (EX-101.PRE) — 12KB
- axon-20240510x8k_htm.xml (XML) — 5KB
07 Submission of Matt ers to a Vote of Security Holders
Item 5.07 Submission of Matt ers to a Vote of Security Holders On May 10, 2024, the Company held its Annual Meeting. The total number of shares of the Company's common stock, par value of $0.00001 per share, voted in person or by proxy at the Annual Meeting was 67,578,597 representing approximately 89.6% of the 75,463,324 shares outstanding as of the March 15, 2024 record date and entitled to vote at the Annual Meeting. The number of votes cast for, against or withheld, as well as abstentions and broker non-votes, if applicable, with respect to each matter considered at the Annual Meeting is set out below. For more information regarding these matters, please refer to the Company's Definitive Proxy Statement relating to the Annual Meeting, which was filed with the SEC on March 29, 2024. Proposal No. 1 — Election of Directors The following nominees were elected directors for a term of one year (and until their successors are elected and qualified) by the votes indicated below. FOR AGAINST WITHHELD BROKER NON-VOTES Erika Ayers Badan Adriane Brown Julie Cullivan Michael Garnreiter Caitlin Kalinowski Matthew R. McBrady Hadi Partovi Graham Smith Patrick W. Smith Jeri Williams 59,722,774 53,703,739 58,786,980 56,589,199 59,536,678 58,854,997 56,900,606 59,006,902 59,828,343 59,683,611 428,073 6,453,662 1,350,154 3,551,722 627,509 1,177,175 3,180,626 1,147,819 414,253 492,392 194,633 188,079 208,346 204,559 181,293 313,308 264,248 190,759 102,844 169,477 7,233,117 7,233,117 7,233,117 7,233,117 7,233,117 7,233,117 7,233,117 7,233,117 7,233,117 7,233,117 Proposal No. 2 — Approval of the Company's Amended and Restated 2022 Stock Incentive Plan The Company's Amended and Restated 2022 Stock Incentive Plan was approved as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 43,819,361 16,399,268 126,851 7,233,117 Proposal No. 3 — Approval of the Company's 2024 eXponential Stock Plan The Company's 2024 eXpo
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Exhibit Description 10.1 Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan, effective as of May 10, 2024 (incorporated by reference to the Definitive Proxy Statement, filed on March 29, 2024). 10.2 Axon Enterprise, Inc. eXponential Stock Plan, effective as of May 10, 2024 (incorporated by reference to the Definitive Proxy Statement, filed on March 29, 2024). 10.3 2024 CEO Performance Award, effective as of December 22, 2023 (incorporated by reference to the Definitive Proxy Statement, filed on March 29, 2024). 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 13, 2024 Axon Enterprise, Inc. By: /s/ ISAIAH FIELDS Isaiah Fields Chief Legal Officer and Corporate Secretary